MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 246 filers reported holding MIRATI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,725,000 | +136.8% | 40,600 | +190.0% | 0.01% | +166.7% |
Q1 2022 | $1,151,000 | -70.2% | 14,000 | -46.8% | 0.00% | -70.0% |
Q4 2021 | $3,858,000 | -46.4% | 26,300 | -35.4% | 0.01% | -47.4% |
Q3 2021 | $7,200,000 | -35.4% | 40,700 | -41.0% | 0.02% | -34.5% |
Q2 2021 | $11,146,000 | -50.9% | 69,000 | -48.0% | 0.03% | -53.2% |
Q1 2021 | $22,714,000 | -23.2% | 132,600 | -1.5% | 0.06% | -21.5% |
Q4 2020 | $29,564,000 | +108.0% | 134,600 | +57.2% | 0.08% | +92.7% |
Q3 2020 | $14,214,000 | +5.7% | 85,600 | -27.3% | 0.04% | +2.5% |
Q2 2020 | $13,449,000 | +59.8% | 117,800 | +7.6% | 0.04% | +25.0% |
Q1 2020 | $8,417,000 | -65.7% | 109,500 | -42.5% | 0.03% | -43.9% |
Q4 2019 | $24,535,000 | +67.9% | 190,400 | +1.5% | 0.06% | +58.3% |
Q3 2019 | $14,616,000 | -15.0% | 187,600 | +12.4% | 0.04% | -16.3% |
Q2 2019 | $17,191,000 | +121.0% | 166,900 | +57.3% | 0.04% | +115.0% |
Q1 2019 | $7,777,000 | +109.3% | 106,100 | +21.1% | 0.02% | +100.0% |
Q4 2018 | $3,716,000 | -2.1% | 87,600 | +8.7% | 0.01% | +11.1% |
Q3 2018 | $3,796,000 | +196.1% | 80,600 | +210.0% | 0.01% | +200.0% |
Q2 2018 | $1,282,000 | – | 26,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |